Mettler-Toledo [MTD] vs Idexx Laboratories [IDXX] Detailed Stock Comparison
Mettler-Toledo
NYSE
Loading...
Idexx Laboratories
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Mettler-Toledo wins in 9 metrics, Idexx Laboratories wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Mettler-Toledo | Idexx Laboratories | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 33.22 | 54.06 | Mettler-Toledo |
| Price-to-Book Ratio | N/A | 35.76 | N/A |
| Debt-to-Equity Ratio | -8.44 | 84.81 | Mettler-Toledo |
| PEG Ratio | 30.81 | 1.11 | Idexx Laboratories |
| EV/EBITDA | 24.59 | 38.16 | Mettler-Toledo |
| Profit Margin (TTM) | 21.46% | 24.41% | Idexx Laboratories |
| Operating Margin (TTM) | 27.37% | 33.62% | Idexx Laboratories |
| EBITDA Margin (TTM) | 27.37% | 33.62% | Idexx Laboratories |
| Return on Equity | -680.23% | 64.87% | Idexx Laboratories |
| Return on Assets (TTM) | 20.82% | 23.26% | Idexx Laboratories |
| Free Cash Flow (TTM) | $864.45M | $798.08M | Mettler-Toledo |
| 1-Year Return | -7.42% | 32.21% | Idexx Laboratories |
| Price-to-Sales Ratio (TTM) | 6.99 | 12.90 | Mettler-Toledo |
| Enterprise Value | $29.16B | $53.14B | Idexx Laboratories |
| EV/Revenue Ratio | 7.54 | 13.16 | Mettler-Toledo |
| Gross Profit Margin (TTM) | 58.98% | 62.62% | Idexx Laboratories |
| Revenue per Share (TTM) | $185 | $50 | Mettler-Toledo |
| Earnings per Share (Diluted) | $39.50 | $12.04 | Mettler-Toledo |
| Beta (Stock Volatility) | 1.35 | 1.50 | Mettler-Toledo |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Mettler-Toledo vs Idexx Laboratories Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Mettler-Toledo | -0.10% | 4.49% | 12.30% | 14.78% | 3.08% | 7.50% |
| Idexx Laboratories | -0.48% | -1.10% | 23.58% | 27.12% | 44.93% | 59.19% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Mettler-Toledo | -7.42% | -1.61% | 36.70% | 330.61% | 1,054.72% | 2,519.96% |
| Idexx Laboratories | 32.21% | 74.14% | 69.73% | 777.14% | 2,182.05% | 4,061.38% |
Performance & Financial Health Analysis: Mettler-Toledo vs Idexx Laboratories
| Metric | MTD | IDXX |
|---|---|---|
| Market Information | ||
| Market Cap | $27.03B | $52.07B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 146,798 | 983,296 |
| 90 Day Avg. Volume | 163,783 | 698,835 |
| Last Close | $1,312.34 | $650.84 |
| 52 Week Range | $946.69 - $1,521.01 | $356.14 - $688.12 |
| % from 52W High | -13.72% | -5.42% |
| All-Time High | $1,714.75 (Dec 27, 2021) | $706.95 (Jul 26, 2021) |
| % from All-Time High | -23.47% | -7.94% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.04% | 0.11% |
| Quarterly Earnings Growth | -0.09% | 0.45% |
| Financial Health | ||
| Profit Margin (TTM) | 0.21% | 0.24% |
| Operating Margin (TTM) | 0.27% | 0.34% |
| Return on Equity (TTM) | -6.80% | 0.65% |
| Debt to Equity (MRQ) | -8.44 | 84.81 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-12.56 | $18.20 |
| Cash per Share (MRQ) | $3.00 | $2.06 |
| Operating Cash Flow (TTM) | $951.67M | $905.81M |
| Levered Free Cash Flow (TTM) | $689.75M | $625.74M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Mettler-Toledo vs Idexx Laboratories
| Metric | MTD | IDXX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 33.22 | 54.06 |
| Forward P/E | 30.81 | 54.42 |
| PEG Ratio | 30.81 | 1.11 |
| Price to Sales (TTM) | 6.99 | 12.90 |
| Price to Book (MRQ) | N/A | 35.76 |
| Market Capitalization | ||
| Market Capitalization | $27.03B | $52.07B |
| Enterprise Value | $29.16B | $53.14B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 7.54 | 13.16 |
| Enterprise to EBITDA | 24.59 | 38.16 |
| Risk & Other Metrics | ||
| Beta | 1.35 | 1.50 |
| Book Value per Share (MRQ) | $-12.56 | $18.20 |
Financial Statements Comparison: Mettler-Toledo vs Idexx Laboratories
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MTD | IDXX |
|---|---|---|
| Revenue/Sales | $983.22M | $998.43M |
| Cost of Goods Sold | $403.35M | $375.05M |
| Gross Profit | $579.88M | $623.38M |
| Research & Development | $49.29M | $59.06M |
| Operating Income (EBIT) | $265.71M | $316.53M |
| EBITDA | $299.44M | $351.81M |
| Pre-Tax Income | $248.66M | $310.08M |
| Income Tax | $46.31M | $67.41M |
| Net Income (Profit) | $202.35M | $242.68M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MTD | IDXX |
|---|---|---|
| Cash & Equivalents | $64.29M | $163.97M |
| Total Current Assets | $1.16B | $1.32B |
| Total Current Liabilities | $1.15B | $1.14B |
| Long-Term Debt | $1.89B | $546.80M |
| Total Shareholders Equity | $-181.98M | $1.45B |
| Retained Earnings | $8.53B | $5.58B |
| Property, Plant & Equipment | N/A | $833.62M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MTD | IDXX |
|---|---|---|
| Operating Cash Flow | $228.93M | $235.07M |
| Capital Expenditures | $-17.26M | $-30.03M |
| Free Cash Flow | $177.19M | $207.94M |
| Debt Repayment | $-479.33M | N/A |
| Common Stock Repurchase | $-218.75M | $-400.89M |
Short Interest & Institutional Ownership Analysis
| Metric | MTD | IDXX |
|---|---|---|
| Shares Short | 683,541 | 2.48M |
| Short Ratio | 4.48 | 4.68 |
| Short % of Float | 0.04% | 0.04% |
| Average Daily Volume (10 Day) | 146,798 | 983,296 |
| Average Daily Volume (90 Day) | 163,783 | 698,835 |
| Shares Outstanding | 20.95M | 81.60M |
| Float Shares | 20.25M | 79.13M |
| % Held by Insiders | 0.00% | 0.01% |
| % Held by Institutions | 1.05% | 0.98% |
Dividend Analysis & Yield Comparison: Mettler-Toledo vs Idexx Laboratories
| Metric | MTD | IDXX |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |